AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
EGFR 20 to 45 With No Albuminuria, and Diabetes or No Diabetes?
The Oxford trials group led by Will Harrington and Richard Haynes designed the study. It was funded by Boringa Ringleheim, the manufacturer of MPa Glifozin. Patients had to have a JFR between 20 and 45 with no restriction on proteinuria. They could not have diabetes. Those who had ketoacidosis in the past five years were excluded.